Neurology

Latest News

Image credit: onephoto - stock.adobe.com
Patient With MS Sues J&J Over ERISA Violation

February 14th 2024

After a patient with multiple sclerosis (MS) was forced to pay exorbitant out-of-pocket costs for a brand name medication when she could’ve gotten a generic for way less, the patient filed a class action complaint against her employer, Johnson & Johnson (J&J), for violating the Employee Retirement Income Security Act of 1974 (ERISA).

globe stethoscope medicine | Image credit: Planetz - stock.adobe.com
IQVIA Projects $192 Billion Loss for Originators by 2028 Thanks to Biosimilar, Generic Competition

January 18th 2024

Q&A With Dr Chelsee Jensen: Navigating FDA Approvals, Challenges in the Biosimilar Landscape
Q&A With Dr Chelsee Jensen: Navigating FDA Approvals, Challenges in the Biosimilar Landscape

January 14th 2024

brain colorful | Image credit: vegefox - stock.adobe.com
EC Approves First MS Biosimilar; Coherus Receives CRL for Neulasta Onpro Competitor

September 27th 2023

globe and an atom
Regulatory Updates From Around the Globe Provide Hope for Biosimilars

September 9th 2023

© 2024 MJH Life Sciences

All rights reserved.